‘Really include everyone in the trial’: A Q&A with the protocol chair of the PhIII monkeypox antiviral study

On Sept. 8, the AIDS Clinical Trials Group and the National Institutes of Health began a Phase III clinical trial of tecovirimat, an antiviral approved by the FDA for smallpox. The placebo-controlled study will look at the efficacy of the drug in reducing lesions and could serve as the basis...

Click to view original post